Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Mahonia aquifolium
Pacific Northwest native used by Indigenous peoples for liver conditions, skin diseases, and as digestive bitter.
Mahonia aquifolium (Oregon grape) is a Pacific Northwest shrub traditionally used by Native Americans as a liver tonic and for skin conditions. Modern research supports its hepatoprotective, antimicrobial, and antipsoriatic properties, attributed primarily to isoquinoline alkaloids such as berberine, berbamine, and hydrastine. Evidence level C indicates limited clinical data, but preliminary studies show promise for psoriasis and digestive health.
Berberine activates AMP-activated protein kinase (AMPK), improving insulin sensitivity and hepatic lipid metabolism, and inhibits bacterial cell division by binding to DNA gyrase. Mahonine and other alkaloids suppress nuclear factor-kappa B (NF-κB) and cyclooxygenase-2 (COX-2) pathways, reducing keratinocyte hyperproliferation in psoriasis. The bitter principles stimulate gastric and bile secretion via bitter taste receptors (TAS2Rs) on the tongue and gut, enhancing digestion. Additionally, berberine modulates gut microbiota and exhibits anti-inflammatory effects through inhibition of toll-like receptor 4 (TLR4) signaling.
Pacific Northwest native used by Indigenous peoples for liver conditions, skin diseases, and as digestive bitter.
Mahonia aquifolium (Oregon grape) is a Pacific Northwest shrub traditionally used by Native Americans as a liver tonic and for skin conditions. Modern research supports its hepatoprotective, antimicrobial, and antipsoriatic properties, attributed primarily to isoquinoline alkaloids such as berberine, berbamine, and hydrastine. Evidence level C indicates limited clinical data, but preliminary studies show promise for psoriasis and digestive health.
Berberine activates AMP-activated protein kinase (AMPK), improving insulin sensitivity and hepatic lipid metabolism, and inhibits bacterial cell division by binding to DNA gyrase. Mahonine and other alkaloids suppress nuclear factor-kappa B (NF-κB) and cyclooxygenase-2 (COX-2) pathways, reducing keratinocyte hyperproliferation in psoriasis. The bitter principles stimulate gastric and bile secretion via bitter taste receptors (TAS2Rs) on the tongue and gut, enhancing digestion. Additionally, berberine modulates gut microbiota and exhibits anti-inflammatory effects through inhibition of toll-like receptor 4 (TLR4) signaling.